What’s New in Psychiatric Times – January Highlights  |  January 9, 2020   The journal psychiatrists read cover-to-cover!   SPECIAL REPORT: Mood Disorders CHAIR: Jonathan E. Alpert, MD, PhD Read these new articles in this month’s print issue! The One-Two Punch: Integrating Psychotherapy & Psychopharmacology Which patients benefit most from combined therapy? Should you attempt to be both therapist and prescriber? A leading expert shares guidance and insights. Overcoming Challenges: Bipolar Disorder in Children & Adolescents Although there has been some advancement, addressing BD in this patient population can be complicated, from conducting a thorough differential diagnosis to sorting through myriad of treatment options. Here: Tips for overcoming these challenges and helping your patients.   Related Content From Psychiatric Times   Antipsychotic Use in Bipolar Disorder: What Does the Evidence Suggest? Dr David Osser discusses the confusion regarding the efficacy of aripiprazole in bipolar mania and depression and its use for preventing bipolar episodes. Read more   Depression Research Roundup Not surprisingly, nicotine, neurotransmitters, and nutrition impact depression. Here: Lessons from recent research. Read more   The Pros & Cons of Ketamine Use The discovery of ketamine’s rapid-acting and robust antidepressant effects has been hailed as “arguably the most important discovery [in neuropsychiatric research] in half a century.” However, this optimism has been tempered by concerns such as long-term safety, durability of clinical benefits, and abuse potential. Read more   Up Next Month: Violence & Trauma